secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2025-11-18T23:59:59+00:00
Accession:  0001999371-25-018108
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharma expands share repurchase program by $25M to $35M total authorized
------------------------------------------------------------------------------

- Board approved an additional $25.0 million for share repurchases, raising total authorized to $35.0 million.
- Repurchases may occur from time to time in open-market or private transactions depending on conditions.
- The original $10 million authorization was increased; no expiration date or commitment to repurchase any specific number of shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125018108/0001999371-25-018108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125018108/tnxp-8k_111825.htm
  HTML page:      https://secwatch.observer/filing/0001999371-25-018108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer